Suven Life Sciences Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 43.87 million compared to INR 11.84 million a year ago. Revenue was INR 45.93 million compared to INR 16.87 million a year ago. Net loss was INR 231.82 million compared to INR 282.98 million a year ago. Basic loss per share from continuing operations was INR 1.59 compared to INR 2.22 a year ago. Diluted loss per share from continuing operations was INR 1.59 compared to INR 2.22 a year ago.
For the six months, sales was INR 79.26 million compared to INR 31.9 million a year ago. Revenue was INR 85.68 million compared to INR 45.33 million a year ago. Net loss was INR 395.08 million compared to INR 675.07 million a year ago. Basic loss per share from continuing operations was INR 2.72 compared to INR 5.3 a year ago. Diluted loss per share from continuing operations was INR 2.72 compared to INR 5.3 a year ago.